Molecular Classification
Cadherin, Type I transmembrane glycoprotein, 7D-cadherins
Other Names
CDH17, Liver-Intestine cadherin, LI-cadherin
Disease Roles
CancerGastric cancer

Cadherin-17 Overview

Cadherin-17 (CDH17), also known as Liver-Intestine cadherin (LI-cadherin), is a calcium-dependent, type I transmembrane glycoprotein belonging to the cadherin superfamily. It is primarily expressed in the gastrointestinal tract, pancreatic ducts and liver, where it mediates homotypic cell-cell adhesion and functions as an intestinal proton-dependent peptide transporter. CDH17 is aberrantly overexpressed in several cancers, notably gastric cancer, where it acts as an oncogenic biomarker due to its involvement in tumor growth regulation via apoptosis signaling pathways. It binds via homophilic interactions and has a different adhesion mechanism than classical cadherins.

Mechanism of Action

Biological Functions

Cell-cell adhesion
Calcium-dependent homotypic cell-cell adhesion
Peptide transporter
Maintenance of tissue structure
Morphogenesis

Disease Associations

Cancer
Gastric cancer

Safety Considerations

No safety concerns listed

Associated Biomarkers

Biomarker
CDH17 overexpression in gastric cancer